share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144:擬議出售證券
美股sec公告 ·  08/07 09:56
Moomoo AI 已提取核心訊息
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 08/07/2024, with an aggregate market value of approximately $1,086,990. The shares were acquired on 02/24/2024 as part of a restricted stock vesting, which was a compensation-related transaction. This planned sale follows a series of transactions over the past three months where Bozic sold a total of 11,400 shares, generating gross proceeds of over $5.4 million.
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 08/07/2024, with an aggregate market value of approximately $1,086,990. The shares were acquired on 02/24/2024 as part of a restricted stock vesting, which was a compensation-related transaction. This planned sale follows a series of transactions over the past three months where Bozic sold a total of 11,400 shares, generating gross proceeds of over $5.4 million.
Vertex Pharmaceuticals Inc.官員Carmen Bozic打算於2024年08月07日賣出共2280股普通股,市值約爲$1,086,990。這些股票於2024年02月24日作爲限制性股票歸屬的一部分獲得,是一項與補償有關的交易。此次擬定的出售計劃是在過去三個月中Bozic進行了一系列交易之後的行動,Bozic一共出售了11400股股票,獲得了超過540萬美元的收益。
Vertex Pharmaceuticals Inc.官員Carmen Bozic打算於2024年08月07日賣出共2280股普通股,市值約爲$1,086,990。這些股票於2024年02月24日作爲限制性股票歸屬的一部分獲得,是一項與補償有關的交易。此次擬定的出售計劃是在過去三個月中Bozic進行了一系列交易之後的行動,Bozic一共出售了11400股股票,獲得了超過540萬美元的收益。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息